Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis

Detalhes bibliográficos
Autor(a) principal: Meinerz,Ana Raquel Mano
Data de Publicação: 2008
Outros Autores: Xavier,Melissa O., Cleff,Marlete Brum, Madrid,Isabel Martins, Nobre,Márcia Oliveira, Meireles,Mário Carlos Araújo, Mello,João Roberto Braga de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Microbiology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025
Resumo: Itraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis.
id SBM-1_4d13c8c428e3bfb7f9b9f4aa40a41019
oai_identifier_str oai:scielo:S1517-83822008000400025
network_acronym_str SBM-1
network_name_str Brazilian Journal of Microbiology
repository_id_str
spelling Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosisitraconazoleterbinafinesporotrichosisantifungalItraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis.Sociedade Brasileira de Microbiologia2008-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025Brazilian Journal of Microbiology v.39 n.4 2008reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S1517-83822008000400025info:eu-repo/semantics/openAccessMeinerz,Ana Raquel ManoXavier,Melissa O.Cleff,Marlete BrumMadrid,Isabel MartinsNobre,Márcia OliveiraMeireles,Mário Carlos AraújoMello,João Roberto Braga deeng2009-04-06T00:00:00Zoai:scielo:S1517-83822008000400025Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2009-04-06T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false
dc.title.none.fl_str_mv Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
title Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
spellingShingle Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
Meinerz,Ana Raquel Mano
itraconazole
terbinafine
sporotrichosis
antifungal
title_short Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
title_full Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
title_fullStr Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
title_full_unstemmed Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
title_sort Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
author Meinerz,Ana Raquel Mano
author_facet Meinerz,Ana Raquel Mano
Xavier,Melissa O.
Cleff,Marlete Brum
Madrid,Isabel Martins
Nobre,Márcia Oliveira
Meireles,Mário Carlos Araújo
Mello,João Roberto Braga de
author_role author
author2 Xavier,Melissa O.
Cleff,Marlete Brum
Madrid,Isabel Martins
Nobre,Márcia Oliveira
Meireles,Mário Carlos Araújo
Mello,João Roberto Braga de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Meinerz,Ana Raquel Mano
Xavier,Melissa O.
Cleff,Marlete Brum
Madrid,Isabel Martins
Nobre,Márcia Oliveira
Meireles,Mário Carlos Araújo
Mello,João Roberto Braga de
dc.subject.por.fl_str_mv itraconazole
terbinafine
sporotrichosis
antifungal
topic itraconazole
terbinafine
sporotrichosis
antifungal
description Itraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis.
publishDate 2008
dc.date.none.fl_str_mv 2008-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1517-83822008000400025
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
dc.source.none.fl_str_mv Brazilian Journal of Microbiology v.39 n.4 2008
reponame:Brazilian Journal of Microbiology
instname:Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
instname_str Sociedade Brasileira de Microbiologia (SBM)
instacron_str SBM
institution SBM
reponame_str Brazilian Journal of Microbiology
collection Brazilian Journal of Microbiology
repository.name.fl_str_mv Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)
repository.mail.fl_str_mv bjm@sbmicrobiologia.org.br||mbmartin@usp.br
_version_ 1752122202175569920